Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome

Abstract Due to frequent and often severe lung affections caused by COVID-19, murine models of acute respiratory distress syndrome (ARDS) are increasingly used in experimental lung research. The one induced by a single lipopolysaccharide (LPS) exposure is practical. However, whether it is preferable...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fatemeh Khadangi, Anne-Sophie Forgues, Sophie Tremblay-Pitre, Alexis Dufour-Mailhot, Cyndi Henry, Magali Boucher, Marie-Josée Beaulieu, Mathieu Morissette, Liah Fereydoonzad, David Brunet, Annette Robichaud, Ynuk Bossé
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/69d659037d924acd87dd3dee7f86e3ac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69d659037d924acd87dd3dee7f86e3ac
record_format dspace
spelling oai:doaj.org-article:69d659037d924acd87dd3dee7f86e3ac2021-12-02T18:15:09ZIntranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome10.1038/s41598-021-87462-x2045-2322https://doaj.org/article/69d659037d924acd87dd3dee7f86e3ac2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87462-xhttps://doaj.org/toc/2045-2322Abstract Due to frequent and often severe lung affections caused by COVID-19, murine models of acute respiratory distress syndrome (ARDS) are increasingly used in experimental lung research. The one induced by a single lipopolysaccharide (LPS) exposure is practical. However, whether it is preferable to administer LPS intranasally or intratracheally remains an open question. Herein, female C57Bl/6 J mice were exposed intranasally or intratracheally to one dose of either saline or 3 mg/kg of LPS. They were studied 24 h later. The groups treated with LPS, either intranasally or intratracheally, exhibited a pronounced neutrophilic inflammation, signs of lung tissue damage and protein extravasation into the alveoli, and mild lung dysfunction. The magnitude of the response was generally not different between groups exposed intranasally versus intratracheally. However, the variability of some the responses was smaller in the LPS-treated groups exposed intranasally versus intratracheally. Notably, the saline-treated mice exposed intratracheally demonstrated a mild neutrophilic inflammation and alterations of the airway epithelium. We conclude that an intranasal exposure is as effective as an intratracheal exposure in a murine model of ARDS induced by LPS. Additionally, the groups exposed intranasally demonstrated less variability in the responses to LPS and less complications associated with the sham procedure.Fatemeh KhadangiAnne-Sophie ForguesSophie Tremblay-PitreAlexis Dufour-MailhotCyndi HenryMagali BoucherMarie-Josée BeaulieuMathieu MorissetteLiah FereydoonzadDavid BrunetAnnette RobichaudYnuk BosséNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fatemeh Khadangi
Anne-Sophie Forgues
Sophie Tremblay-Pitre
Alexis Dufour-Mailhot
Cyndi Henry
Magali Boucher
Marie-Josée Beaulieu
Mathieu Morissette
Liah Fereydoonzad
David Brunet
Annette Robichaud
Ynuk Bossé
Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
description Abstract Due to frequent and often severe lung affections caused by COVID-19, murine models of acute respiratory distress syndrome (ARDS) are increasingly used in experimental lung research. The one induced by a single lipopolysaccharide (LPS) exposure is practical. However, whether it is preferable to administer LPS intranasally or intratracheally remains an open question. Herein, female C57Bl/6 J mice were exposed intranasally or intratracheally to one dose of either saline or 3 mg/kg of LPS. They were studied 24 h later. The groups treated with LPS, either intranasally or intratracheally, exhibited a pronounced neutrophilic inflammation, signs of lung tissue damage and protein extravasation into the alveoli, and mild lung dysfunction. The magnitude of the response was generally not different between groups exposed intranasally versus intratracheally. However, the variability of some the responses was smaller in the LPS-treated groups exposed intranasally versus intratracheally. Notably, the saline-treated mice exposed intratracheally demonstrated a mild neutrophilic inflammation and alterations of the airway epithelium. We conclude that an intranasal exposure is as effective as an intratracheal exposure in a murine model of ARDS induced by LPS. Additionally, the groups exposed intranasally demonstrated less variability in the responses to LPS and less complications associated with the sham procedure.
format article
author Fatemeh Khadangi
Anne-Sophie Forgues
Sophie Tremblay-Pitre
Alexis Dufour-Mailhot
Cyndi Henry
Magali Boucher
Marie-Josée Beaulieu
Mathieu Morissette
Liah Fereydoonzad
David Brunet
Annette Robichaud
Ynuk Bossé
author_facet Fatemeh Khadangi
Anne-Sophie Forgues
Sophie Tremblay-Pitre
Alexis Dufour-Mailhot
Cyndi Henry
Magali Boucher
Marie-Josée Beaulieu
Mathieu Morissette
Liah Fereydoonzad
David Brunet
Annette Robichaud
Ynuk Bossé
author_sort Fatemeh Khadangi
title Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
title_short Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
title_full Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
title_fullStr Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
title_full_unstemmed Intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
title_sort intranasal versus intratracheal exposure to lipopolysaccharides in a murine model of acute respiratory distress syndrome
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/69d659037d924acd87dd3dee7f86e3ac
work_keys_str_mv AT fatemehkhadangi intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT annesophieforgues intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT sophietremblaypitre intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT alexisdufourmailhot intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT cyndihenry intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT magaliboucher intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT mariejoseebeaulieu intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT mathieumorissette intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT liahfereydoonzad intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT davidbrunet intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT annetterobichaud intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
AT ynukbosse intranasalversusintratrachealexposuretolipopolysaccharidesinamurinemodelofacuterespiratorydistresssyndrome
_version_ 1718378396805758976